Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis

N/ACompletedNCT02083133

Cook County Health496 enrolled

Overview

The purpose of this study is to assess whether the current recommendation for a 50% dose reduction in insulin for diabetic patients with a creatinine clearance (CrCl) ≤15 mL/min or on hemodialysis results in an increased number of hypoglycemic episodes.

Study Type

OBSERVATIONAL

Enrollment

496

Conditions

Diabetes Hypoglycemia Renal Dysfunction Insulin Dosing

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Inpatient men and women 18 years of age and older with a diagnosis of type 2 diabetes mellitus (T2DM) with CrCl ≥60, 16-59 or ≤15 milliliters/minute. Exclusion Criteria: * Patients less than 18 years of age, pregnant patients

Locations (1)

John H Stroger Hospital of Cook County

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Hypoglycemia

Time frame: Last 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.